These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 4652594)
21. Interactions between physicians and the pharmaceutical industry: what does the literature say? Lexchin J CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424 [TBL] [Abstract][Full Text] [Related]
22. Future shock: drug therapy and the U.S. pharmaceutical industry. Ellenhorn MJ J Clin Pharmacol; 1975; 15(5-6):385-400. PubMed ID: 1133216 [No Abstract] [Full Text] [Related]
24. Dietary supplements: background for dialogue between the industry and the medical profession. Friede AI Food Drug Law J; 1998; 53(3):413-20. PubMed ID: 10346719 [No Abstract] [Full Text] [Related]
25. Present attitudes of governmental drug regulatory agencies. Noel PR Int J Clin Pharmacol; 1973 Apr; 7(2):168-77. PubMed ID: 4731283 [No Abstract] [Full Text] [Related]
26. The United States Pharmacopeia. Its value to the professions. Heller WM JAMA; 1970 Jul; 213(4):576-9. PubMed ID: 4914287 [No Abstract] [Full Text] [Related]
27. FDA wins spoof award for its "collusion" with the drug industry. Lenzer J BMJ; 2005 Mar; 330(7491):555. PubMed ID: 15760976 [No Abstract] [Full Text] [Related]
28. FUNCTION OF THE USAN COUNCIL. JEROME JB Am J Pharm Sci Support Public Health; 1964; 136():107-13. PubMed ID: 14167235 [No Abstract] [Full Text] [Related]
29. [Standardization as a basis planning and administration in drug industry and pharmacy (II)]. Wagler M Pharm Prax; 1970; 7():151-3. PubMed ID: 5469874 [No Abstract] [Full Text] [Related]
30. HOW THE FOOD AND DRUG ADMINISTRATION EVALUATES NEW DRUG APPLICATIONS. LARRICK GP J New Drugs; 1964; 4(2):63-74. PubMed ID: 14197105 [No Abstract] [Full Text] [Related]
32. Drug product equivalence--the problem, the challenge and the USP. Macek TJ J Am Pharm Assoc; 1972 Jan; 12(1):26-8. PubMed ID: 5007260 [No Abstract] [Full Text] [Related]
33. Standardization of forensic drug analyses. Frank RS; Gunn JW J Forensic Sci; 1974 Jan; 19(1):163-7. PubMed ID: 4854386 [No Abstract] [Full Text] [Related]
34. Physicians, pharmaceutical representatives, and patients: who really benefits? Westfall JM J Fam Pract; 2000 Sep; 49(9):817-9. PubMed ID: 11032206 [No Abstract] [Full Text] [Related]
35. Evolution of a children's drug table. Shirkey HC Hosp Formul; 1979 Mar; 14(3):319-20, 325-6, 330. PubMed ID: 10316796 [No Abstract] [Full Text] [Related]
36. Standardization of drug names. Allan FM JAMA; 1974 Jul; 229(5):541-3. PubMed ID: 4406898 [No Abstract] [Full Text] [Related]
37. The pharmaceutical revolution: its impact on science and society. Lasagna L Science; 1969 Dec; 166(3910):1227-33. PubMed ID: 5350314 [No Abstract] [Full Text] [Related]
38. Prescription drug advertising--should states regulate what is false and misleading? Shaeffer J Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454 [No Abstract] [Full Text] [Related]
39. Thalidomide and beyond: some recommendations regarding public policies toward the ethical drug industry. Schifrin LG Int J Health Serv; 1974; 4(1):147-55. PubMed ID: 4829893 [No Abstract] [Full Text] [Related]
40. An overview from the United States. Besselaar GH; Tempero KF Clin Pharmacol Ther; 1974 Sep; 16(3):620-4. PubMed ID: 4411989 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]